Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Somatropin in Combination With Leuprorelin Compared to Somatropin Alone in Pubertal Children With Idiopathic Short Stature

NCT00355030 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00355030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00355030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Somatropin in Combination With Leuprorelin Compared to Somatropin Alone in Pubertal Children With Idiopathic Short Stature
Lead sponsor
Eli Lilly and Company
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2006
Completion date
July 31, 2015
Enrollment
91 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic short stature (iss)